accessnewswire.com · Oct 13, 2026
NYSE American (AMEX)
15-minute delay
NANOVIRICIDES, INC. COVERAGE
Latest NanoViricides, Inc. news
MARKET NEWS
Around the market
accessnewswire.com · Oct 6, 2026
NanoViricides Presenting at NIBA's 153rd Investment Conference in Fort Lauderdale, FL October 7, 2026
Read article →
accessnewswire.com · Oct 5, 2026
NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Read article →
accessnewswire.com · Sep 29, 2026
NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Is In Phase II Clinical Trials
Read article →
accessnewswire.com · Sep 28, 2026
Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Read article →
accessnewswire.com · Sep 23, 2026
Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Read article →KEY DATA POINTS
Financial snapshot
Revenue, profitability, balance-sheet, cash-flow, and valuation trends for NanoViricides, Inc..
AMEX MARKET COMPARABLES
Similar companies
Ten established AMEX listings presented for broader market context.
AMEX reference
15-minute delay
OBE
Obsidian Energy
Energy
→
UEC
Uranium Energy
Uranium
→
CDE
Coeur Mining
Precious metals
→
IAG
IAMGOLD
Gold mining
→
NGD
New Gold
Gold mining
→
APT
Alpha Pro Tech
Protective products
→
SVM
Silvercorp Metals
Silver mining
→
EXK
Endeavour Silver
Silver mining
→
GORO
Gold Resource
Gold mining
→
USAS
Americas Gold and Silver
Precious metals
→
TradingView renders the market-data table. Securities.io supplies only the editorial peer selection, comparison labels, and destination links.
COMPANY DETAILS
About NanoViricides, Inc.
Business description, sector, industry, leadership, headquarters, and workforce information.
SECURITIES.IO RESEARCH
Continue your research
AMEX market data on this page is labeled as 15 minutes delayed. Prices, charts, financials, company information, and the peer comparison are displayed by TradingView; Securities.io does not extract those values. This information is educational and is not investment advice.